Gene editing, which effectively allows the precise "cutting and pasting" of DNA, is already used in basic research and clinical studies that involve non-heritable "somatic" cells.

This point is non-controversial, and has been apparent for quite a while - over a year ago, for instance, I wrote a post listing the places where the missing heritable risk could be hiding.